Cellebrite DI Ltd
NASDAQ:CLBT

Watchlist Manager
Cellebrite DI Ltd Logo
Cellebrite DI Ltd
NASDAQ:CLBT
Watchlist
Price: 12.7 USD -0.24% Market Closed
Market Cap: $3.2B

EV/S

5.7
Current
13%
Cheaper
vs 3-y average of 6.6

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
5.7
=
Enterprise Value
$3.1B
/
Revenue
$475.7m

Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.

EV/S
5.7
=
Enterprise Value
$3.1B
/
Revenue
$475.7m

Valuation Scenarios

Cellebrite DI Ltd is trading below its 3-year average

If EV/S returns to its 3-Year Average (6.6), the stock would be worth $14.63 (15% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-58%
Maximum Upside
+15%
Average Downside
22%
Scenario EV/S Value Implied Price Upside/Downside
Current Multiple 5.7 $12.7
0%
3-Year Average 6.6 $14.63
+15%
5-Year Average 6.1 $13.44
+6%
Industry Average 2.4 $5.33
-58%
Country Average 2.8 $6.25
-51%

Forward EV/S
Today’s price vs future revenue

Today's Enterprise Value Revenue Forward EV/S
$3.1B
/
Jan 2026
$475.7m
=
5.7
Current
$3.1B
/
Dec 2026
$577.7m
=
5.3
Forward
$3.1B
/
Dec 2027
$678.7m
=
4.5
Forward
$3.1B
/
Dec 2028
$787.4m
=
3.9
Forward
$3.1B
/
Dec 2029
$880.7m
=
3.5
Forward

Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
EV/S
P/E
All Countries
Close

Market Distribution

In line with most companies in Israel
Percentile
67th
Based on 462 companies
67th percentile
5.7
Low
0.1 — 1.3
Typical Range
1.3 — 6.7
High
6.7 —
Distribution Statistics
Israel
Min 0.1
30th Percentile 1.3
Median 2.8
70th Percentile 6.7
Max 2 509.1

Cellebrite DI Ltd
Glance View

Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism. The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.

CLBT Intrinsic Value
12.46 USD
Overvaluation 2%
Intrinsic Value
Price $12.7
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett